Tissue Regenix Group plc (AIM:TRX)
London
· Delayed Price · Currency is GBP · Price in GBX 29.50
+0.45 (1.53%)
Jun 27, 2025, 4:35 PM GMT+1
Tissue Regenix Group Market Cap
Tissue Regenix Group has a market cap or net worth of 21.01 million as of June 27, 2025. Its market cap has decreased by -54.09% in one year.
Market Cap
21.01M
Enterprise Value
27.27M
Revenue
22.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.50
Market Cap Chart
Since June 29, 2010, Tissue Regenix Group's market cap has decreased from 41.00M to 21.01M, a decrease of -48.75%. That is a compound annual growth rate of -4.36%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.91B |
| GSK plc | 56.45B |
| Haleon | 34.45B |
| Smith & Nephew | 9.59B |
| ConvaTec Group | 5.93B |
| Hikma Pharmaceuticals | 4.49B |
| HUTCHMED (China) | 1.93B |
| Genus | 1.26B |